Charles Lambert
About Charles Lambert
Charles R. Lambert serves as Senior Vice President of Finance and Treasurer at Medical Properties Trust (MPW), and is listed among MPT’s officers in 2025 supplemental filings; he is also designated as the Company contact for equity-related agreements and notices (address and email on file) . Background details such as education, age, and start date/tenure are not disclosed in available filings. Company performance context during 2022–2024 shows declining TSR and stock price, with mixed revenue/EBITDA trends (tables below) *.
Past Roles
No prior roles for Mr. Lambert are disclosed in the DEF 14A or 8-K filings reviewed .
External Roles
No external directorships or roles for Mr. Lambert are disclosed in the DEF 14A filings reviewed .
Fixed Compensation
- Mr. Lambert is not a Named Executive Officer (NEO); individual base salary, target bonus, and perquisites are not disclosed for him in the Summary Compensation Tables .
Performance Compensation
- SVP equity: MPW granted SVPs cash-settled restricted stock units with share-price hurdles similar to CEO/CFO awards in late 2023; CEO/CFO awards require at least 67% share price appreciation before any RSUs can be earned (SVPs “were granted similar awards with the same share price targets”) .
- Annual bonuses in 2024 applied formally to CEO/CFO; SVP bonuses (e.g., Hanna/Hooper/Portal) were determined by the CEO based on a holistic review. Mr. Lambert’s bonus specifics are not detailed in the proxies .
2024 Annual Cash Bonus Framework (CEO/CFO)
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Leverage & Maturities reduction | 50% | Not disclosed | Not disclosed | Not disclosed | Cash (annual bonus) |
| Operating Expenses reduction vs FY2022 | 15% | Not disclosed | Not disclosed | Not disclosed | Cash (annual bonus) |
| Tenant-related objectives | 15% | Not disclosed | Not disclosed | Not disclosed | Cash (annual bonus) |
| Corporate-related objectives (leadership, outreach, ESG) | 20% | Not disclosed | Not disclosed | Not disclosed | Cash (annual bonus) |
| Performance-based equity (cash-settled RSUs) | — | ≥67% stock price appreciation from grant | Not disclosed | Not disclosed | Earn-out per hurdle |
Applicability: Formal metric weighting applies to CEO/CFO; SVPs had similar share-price hurdle equity awards; SVP cash bonus determinations were discretionary (Lambert’s specifics not disclosed) .
Equity Ownership & Alignment
- Stock ownership guidelines: SVPs must hold 1.5x base salary in MPW shares within five years of becoming SVP; MPW reports all SVPs were in compliance as of March 18, 2025 (and as of March 20, 2024, some SVPs were still within compliance windows) .
- Hedging/Pledging: Prohibited for all employees/directors, including executives. Policy bans short sales, derivative hedges/monetization, and pledging MPW shares as collateral .
- Options: MPW states it has not granted stock options to NEOs and has not granted options since initial director grants in 2004 (applies company-wide practice) .
- Individual beneficial ownership: MPW discloses beneficial ownership for directors and NEOs; Lambert is not individually listed. Executives as a group held ~1.26% of shares outstanding as of March 18, 2025 .
Ownership Guidelines & Compliance
| Role | Multiple of Base Salary Required | Compliance Status |
|---|---|---|
| CEO | 6x | Yes |
| EVP (CFO) | 4x | Yes |
| SVPs | 1.5x | Yes (all SVPs; includes Lambert) |
| Non-Employee Directors | 3x | Yes |
Trading Controls
- Prior authorization required for any purchase/sale by employees/directors .
- No hedging or pledging permitted .
Employment Terms
- Founder agreements: Only CEO and CFO have 2003 employment agreements (auto-renew, severance, and change-of-control protections). Company commits not to include evergreen terms, single-trigger CoC, or excise tax gross-ups in new contracts .
- Severance/CoC: Potential payments tables are provided for CEO/CFO and certain SVPs; Mr. Lambert not listed. SVP rows show equity acceleration amounts but no cash severance; individual terms for Lambert are not disclosed .
- Clawbacks: Company adopted a 2023 Clawback Policy compliant with SEC/NYSE; legacy 2013 clawback policy applies to pre-2023 awards in cases of misconduct/fraud/gross negligence .
Performance & Track Record
- Pay versus performance data shows TSR and stock price declines in 2022–2024; “Compensation Actually Paid” fluctuated materially with performance (CEO metrics shown for context) .
- Company revenue/EBITDA trends are mixed across 2022–2024 (see table; S&P Global data).
Company TSR and Stock Price (for performance context)
| Metric | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Company TSR ($ value of $100) | 63.54 | 31.62 | 28.07 |
| Stock Price ($) | 11.14 | 4.91 | 3.95 |
Company Financials (context during Lambert’s tenure window)
| Metric (USD) | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenues | $1,173,033,000* | $675,481,000* | $883,163,000* |
| EBITDA | $1,390,060,000* | $387,978,000* | $713,743,000* |
| EBITDA Margin % | 87.78%* | 43.80%* | 68.72%* |
*Values retrieved from S&P Global.
Additional Signals Relevant to Lambert’s Role
- Role visibility: Lambert is listed as SVP Finance & Treasurer across multiple 2025 supplemental filings and is the designated “Attention” contact for certain equity/ATM agreements, indicating direct involvement in capital markets/treasury operations .
- Equity awards: SVPs received cash-settled RSUs with share-price hurdles mirroring CEO/CFO targets (≥67% price appreciation), aligning SVP payouts with shareholder value creation; no options outstanding .
Investment Implications
- Alignment: Prohibition on hedging/pledging plus SVP ownership guideline compliance support “skin-in-the-game” alignment; SVP awards tied to stock price appreciation (≥67% hurdle) suggest high sensitivity to TSR recovery before meaningful payouts .
- Retention risk: With TSR and stock price depressed in 2022–2024, realizable value of performance-linked equity can be constrained, potentially increasing retention risk for finance/treasury talent unless future performance improves; Lambert’s individual vesting/bonus specifics are not disclosed, limiting precision of pay-for-performance analysis .
- Trading pressure: Anti-hedging/pledging and preclearance requirements reduce near-term selling pressure signals; absence of disclosed Form 4 activity for Lambert in reviewed materials limits insider-selling assessment .
- Governance comfort: Updated clawback policy and avoidance of single-trigger CoC/excise tax gross-ups in new agreements are shareholder-friendly; lack of individual contract details for Lambert remains a diligence gap .
Key diligence gaps: Mr. Lambert’s exact compensation (salary/bonus/equity amounts), vesting schedules, severance/CoC terms, and personal beneficial ownership are not itemized in proxies; consider reviewing Form 4 filings and any employment letter/8-K 5.02 specific to Lambert for completeness.